Biogennix LLC, based in Irvine, CA, is a leading provider of advanced synthetic bone graft products aimed at enhancing patient outcomes in orthopedic and spine surgery. Their innovative TrelCor technology integrates nanotechnology with a biomimetic composition and structure to optimize the bone regeneration process.
With a focus on cutting-edge technology and advanced biologic concepts, Biogennix is dedicated to improving patient care through the development of products like Agilon, Morpheus, osteoSPAN, and the DirectCell System. Their commitment to innovation and clinical success has positioned them as a trusted partner for surgeons seeking high-quality osteobiologic solutions.
Generated from the website